Heavy medicine holding: it is expected that the net profit in the first half of 2025 will increase by 9.2%-26% year-on-year.

Heavy Medicine Holdings Announcement: It is expected that the net profit attributable to shareholders of the listed company from January 1, 2025 to June 30, 2025 will be between 260 million and 300 million RMB, a year-on-year growth of 9.2% to 26%. The net profit after deducting non-recurring gains and losses is expected to be between 250 million and 280 million RMB, a year-on-year growth of 14.39% to 28.12%. The basic earnings per share is expected to be between 0.15 RMB/share and 0.17 RMB/share.